Clinical studies recruiting near Orlando

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · AdventHealth Orlando · Eli Lilly and Company · NCT07218380 Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Central Florida Pulmonary Group, P.A. · Philip Morris Products S.A. · NCT07108166 Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
NA · Orlando Health · Analog Device, Inc. · NCT05650541 Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NA · Duke University · NCT06906627 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Orlando Health Cancer Institute ( Site 0030) · Merck Sharp & Dohme LLC · NCT06393374 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Arnold Palmer Hospital for Children · National Cancer Institute (NCI) · NCT05099003 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Orlando Immunology Center ( Site 1501) · Merck Sharp & Dohme LLC · NCT07266831 Study of XB010 in Subjects With Solid Tumors
Phase 1 · Sarah Cannon Research Institute at Florida Cancer Specialist · Exelixis · NCT06545331 A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Phase 1/Phase 2 · Sarah Cannon Research Institute at Florida Cancer Specialist · IDEAYA Biosciences · NCT07174583 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · AdventHealth Orlando · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Orlando Health Cancer Institute · NRG Oncology · NCT05624996 A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Phase 1/Phase 2 · Advent Health · SURGE Therapeutics · NCT05710848 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · CTR Oakwater, LLC · Boehringer Ingelheim · NCT07355296 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Phase 1 · Florida Cancer Specialists Lake Nona Drug Development Unit · TORL Biotherapeutics, LLC · NCT06005740 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Apg Research, Llc · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
NA · Orlando Health · Orlando Health, Inc. · NCT06178315 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Nemours Children's Hospital - Orlando · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Arnold Palmer Hospital for Children · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · AdventHealth Orlando · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Arnold Palmer Hospital for Children · Giselle Sholler · NCT02559778 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · Apg Research, Llc · Bristol-Myers Squibb · NCT07288567 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · AdventHealth Orlando · Eli Lilly and Company · NCT07415044 Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study
Phase N/A · Orlando Health (Data Collection Only) · Memorial Sloan Kettering Cancer Center · NCT07318402 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Orlando Immunology Center ( Site 0021) · Merck Sharp & Dohme LLC · NCT07044297 An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
NA · University of Central Florida · University of Maryland, College Park · NCT06058455 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Arnold Palmer Hospital for Children · Alliance for Clinical Trials in Oncology · NCT07091617 A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Phase 1/Phase 2 · Site-105 · Biohaven Therapeutics Ltd. · NCT06384807 Effectiveness of Interventions to Promote Physical Activity During Pregnancy
NA · Orlando Health · University of Central Florida · NCT07223112

Look up another city

Look up another condition